PHVS:Ord/Pharvaris NV - Stock Price Quote and Dividend Data
PHVS STOCK PRICE LATEST CLOSE
$12.30
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Pharmaceuticals
Ord/Pharvaris NV Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
Ord/Pharvaris NV Stock Price Information
52-Week Low/High Stock Price$11.76 - $25.50
Percent Held by Institutions7.88%
Revenue$0
Net Income$-168,982,467
Cash Flow$-155,083,873
EPS-0.64%
Market Cap$375,383,700
PE Ratio to Industry42%
Debt-Equity Ratio0.08%
Debt-Equity to Industry1.42%
Total Return Last 12 Months-46.85%
Total Return Last 3 Years-33.33%
Total Return Last 5 Years0.00%
Latest Trade DateApr. 09, 2025
Ord/Pharvaris NV Annual Stock Dividends
No Data available for Payment History.
Ord/Pharvaris NV Dividend Payment History
| No dividends retrieved for PHVS |
Ord/Pharvaris NV Other Dividend Details
Pharvaris is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for rare diseases with unmet need, initially focused on angioedema and other bradykinin-mediated diseases. Co.'s first molecule, PHA121, is a small-molecule bradykinin B2-receptor antagonist for the treatment of hereditary angioedema, or HAE. PHA121 has been observed to be a potent inhibitor in vitro as assessed using human recombinant bradykinin B2 receptors (150 pM); ex vivo as studied against endogenous bradykinin B2 receptors in a human umbilical vein model (350 pM); and in vivo in the human bradykinin-challenge model (170 pM).
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Apr. 09, 2025PHVS STOCK PRICE DECREASE: Ord/Pharvaris NV on 04-09-2025 decreased stock price > 10% from $13.21 to $11.83
Dec. 03, 2024PHVS STOCK PRICE DECREASE: Ord/Pharvaris NV on 12-03-2024 decreased stock price > 10% from $21.90 to $19.15
Nov. 08, 2024PHVS STOCK PRICE DECREASE: Ord/Pharvaris NV on 11-08-2024 decreased stock price > 10% from $25.01 to $22.32
Oct. 12, 2024PHVS STOCK PRICE INCREASE: Ord/Pharvaris NV on 10-12-2024 increased stock price > 10% from $17.83 to $19.73
Sep. 06, 2024PHVS STOCK PRICE INCREASE: Ord/Pharvaris NV on 09-06-2024 increased stock price > 10% from $17.31 to $19.10
Aug. 16, 2024PHVS STOCK PRICE INCREASE: Ord/Pharvaris NV on 08-16-2024 increased stock price > 10% from $16.90 to $19.19
Aug. 14, 2024PHVS STOCK PRICE INCREASE: Ord/Pharvaris NV on 08-14-2024 increased stock price > 10% from $15.73 to $18.28
Jun. 13, 2024PHVS STOCK PRICE INCREASE: Ord/Pharvaris NV on 06-13-2024 increased stock price > 10% from $15.88 to $18.20
Apr. 19, 2024PHVS STOCK PRICE DECREASE: Ord/Pharvaris NV on 04-19-2024 decreased stock price > 10% from $21.00 to $18.42
Mar. 27, 2024PHVS STOCK PRICE INCREASE: Ord/Pharvaris NV on 03-27-2024 increased stock price > 10% from $21.26 to $23.69
Apr. 10, 2025IBO STOCK PRICE DECREASE: Impact Biomedical Inc on 04-10-2025 decreased stock price > 10% from $0.65 to $0.52
Apr. 10, 2025SXTP STOCK PRICE DECREASE: 60 Degrees Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $2.87 to $2.50
Apr. 10, 2025BMYMP STOCK PRICE DECREASE: $2 Cv. Pfd./Bristol Myers Squibb Co. on 04-10-2025 decreased stock price > 10% from $1,003.20 to $901.50
Apr. 10, 2025PBMWW STOCK PRICE DECREASE: Wt Exp/Psyence Biomedical Ltd on 04-10-2025 decreased stock price > 10% from $0.03 to $0.02
Apr. 10, 2025UPC STOCK PRICE DECREASE: Ord Shs (New)/Universe Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $3.95 to $3.28
Apr. 10, 2025SXTPW STOCK PRICE DECREASE: Wt Exp/60 Degrees Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $0.07 to $0.04
Apr. 10, 2025RGBP STOCK PRICE DECREASE: Regen BioPharma Inc on 04-10-2025 decreased stock price > 10% from $0.06 to $0.05
Apr. 10, 2025DRRX STOCK PRICE DECREASE: Durect Corp on 04-10-2025 decreased stock price > 10% from $0.80 to $0.71
Apr. 10, 2025IXHL STOCK PRICE DECREASE: Incannex Healthcare Inc on 04-10-2025 decreased stock price > 10% from $0.84 to $0.68
Apr. 10, 2025CLABF STOCK PRICE DECREASE: Com No Par/Core One Labs Inc on 04-10-2025 decreased stock price > 10% from $0.09 to $0.04
